H3K27me3 ChIPSeq_abl_GSK treated
Homo sapiens
source_name
abl_GSK treated
cell line
LNCaP-abl (abl)
cell types
castration resitant prostate cancer cells
cell phenotype
AR-positive, EZH2 inhibitor-sensitive
passages
61-64
treated with
GSK126
chip antibody
H3K27 trimethylation (Cell Signaling, C36B11, #9733S) and H2Av (Active Motif 39715)